Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 7, 2018
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjectsChadi G Abdallah, Henk M De Feyter, Lynnette A Averill, et al.
The Journal of Clinical Investigation|September 12, 2017
Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinasesHiroshi Nishi, Kazuhiro Furuhashi, Xavier Cullere, et al.
The Journal of Infectious Diseases|April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccinesS Zolla-Pazner, C Alving, R Belshe, et al.
The Journal of Infectious Diseases|July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteersT G Evans, M C Keefer, K J Weinhold, et al.
Neuroimage|June 24, 2010
Imaging haemodynamic changes related to seizures: comparison of EEG-based general linear model, independent component analysis of fMRI and intracranial EEGR C Thornton, R Rodionov, H Laufs, et al.
The Journal of Infectious Diseases|February 1, 1996
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupJ R Mascola, S W Snyder, O S Weislow, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 29, 2023
Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence settingAlyssa G Burrows, Sophia Linton, Jenny Thiele, et al.
The Journal of Infectious Diseases|May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation GroupM L Clements-Mann, K Weinhold, T J Matthews, et al.
Pageof 18